Differentiation tracing identifies hematopoietic regeneration from multipotent progenitors but not stem cells
Cells & Development · 2023
DOI: 10.1016/j.cdev.2023.203861 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells & Development, 2023. Verfasst von Tamar Nizharadze und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Theoretical Systems Biology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Hauptthemen laut MEDLINE: Hematopoietic Stem Cells, Hematopoiesis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Hermann von Helmholtz-Gemeinschaft Deutscher Forschungszentren, European Research Council.
Abstract (Originalsprache)
Hematopoietic stem cells (HSCs) and multipotent progenitors (MPPs) generate the immune system in development, and contribute to its maintenance under steady-state conditions. How stem and progenitor cells respond to increased demand for mature cells upon injury is a fundamental question of stem cell biology. Several studies of murine hematopoiesis have reported increased proliferation of HSCs in situ when exposed to inflammatory stimuli, which has been taken as a proxy for increased HSC differentiation. Such surplus generation of HSC may fuel enhanced HSC differentiation or, alternatively, maintain HSC cellularity in the face of increased cell death without enhanced HSC differentiation. This key question calls for direct measurements of HSC differentiation in their natural niches in vivo. Here, we review work that quantifies native HSC differentiation by fate mapping and mathematical inference. Recent differentiation tracing studies show that HSC do not increase their differentiation rate upon a wide range of challenges, including systemic bacterial infection (sepsis), blood loss, and transient or persistent ablation of specific mature immune cells. By contrast, MPPs differentiate more rapidly in response to systemic infection to accelerate the production of myeloid cells. These new in vivo data identify MPPs as a major source of hematopoietic regeneration; HSCs might not contribute to regeneration while remaining protected.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Theoretical Systems Biology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
- Division of Cellular Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Faculty of Medicine, Heidelberg University, 69120 Heidelberg, Germany.
- Division of Cellular Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
- Division of Cellular Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Electronic address: hr.rodewald@dkfz.de.
- Division of Theoretical Systems Biology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Electronic address: t.hoefer@dkfz.de.
Förderung
- Deutsche Forschungsgemeinschaft
- Hermann von Helmholtz-Gemeinschaft Deutscher Forschungszentren
- European Research Council
Zitieren
APA
Nizharadze, T., Busch, K., Fanti, A. K., Rodewald, H. R., & Höfer, T. (2023). Differentiation tracing identifies hematopoietic regeneration from multipotent progenitors but not stem cells. Cells & Development. https://doi.org/10.1016/j.cdev.2023.203861
Vancouver
Nizharadze T, Busch K, Fanti AK, Rodewald HR, Höfer T. Differentiation tracing identifies hematopoietic regeneration from multipotent progenitors but not stem cells. Cells & Development. 2023. doi:10.1016/j.cdev.2023.203861
BibTeX
@article{Nizharadze2023,
author = {Nizharadze, Tamar and Busch, Katrin and Fanti, Ann-Kathrin and Rodewald, Hans-Reimer and Höfer, Thomas},
title = {Differentiation tracing identifies hematopoietic regeneration from multipotent progenitors but not stem cells},
journal = {Cells & Development},
year = {2023},
doi = {10.1016/j.cdev.2023.203861}
}
EUVIMED